Molecular Mechanism of Arsenic Carcinogenesis
砷致癌的分子机制
基本信息
- 批准号:8632516
- 负责人:
- 金额:$ 33.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-15 至 2018-10-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsArsenicBindingCellsChronicDNA MethylationDevelopmentDown-RegulationERBB2 geneEndothelial CellsEnvironmental ExposureEpithelial CellsExposure toFutureGenerationsHumanIL8 geneLeadLungMalignant NeoplasmsMalignant neoplasm of liverMalignant neoplasm of lungMicroRNAsModelingMolecularMolecular BiologyNADPH OxidaseNF-Kappa B p65NF-kappa BOxidative StressPlayPreventionPrevention strategyProductionProto-OncogenesReactive Oxygen SpeciesRoleSignal PathwaySignal TransductionSignaling MoleculeSkin CancerT-LymphocyteTestingTumor AngiogenesisWorkangiogenesisbasecancer typecarcinogenesiscell transformationexposed human populationin vivonovelnovel therapeuticsparacrineprotein expressionpublic health relevancereceptortumortumor growth
项目摘要
DESCRIPTION (provided by applicant): Long-term human exposure to inorganic arsenic induces lung and other cancers. The molecular mechanisms of arsenic-induced carcinogenesis remain to be elucidated. Our preliminary studies show that arsenic increases reactive oxygen species (ROS) production, inhibits miR-199 and miR-148 expression, and increases ERBB2, PKM2, NF-kB, HIF-1 and IL-8 expression in lung epithelial cells. Arsenic treatment also induces cell transformation, tumor growth and angiogenesis. We hypothesize that arsenic suppresses miR-199/148 expression through the induction of NOX2, p47phox, ROS; and DNMT1 expression; and miR-199/148 downregulation regulates carcinogenesis (cell transformation, tumor growth, and angiogenesis) through targets: ERBB2 and PKM2/NF-:B. To test this hypothesis, three aims are proposed. Aim 1 will investigate the mechanisms of arsenic in suppressing miR-199 and miR-148 expression through NOX2/p47phox/DNMT1 induction, ROS generation; and miR-199/148 downregulation in turn regulates ERBB2 expression and PKM2/NF-kB interaction. We will investigate: 1) whether arsenic suppresses miR-199 and miR-148 expression through the induction of NOX2, p47Phox, ROS, and DNMT1; 2) whether arsenic induces ERBB2 and PKM2 expression by miR-199/148 downregulation; 3) what regions of PKM2 bind with NF-kB p65 subunit for regulating IL-8 and HIF-1 expression. Aim 2 will investigate the roles of miR-199/148 downregulation in inducing ERBB2 and PKM2/NF-kB expression for regulating cell transformation and tumor growth. We will determine: 1) whether arsenic induces cell transformation and tumor growth through ROS- and DNMT1-induced miR-199/148 downregulation; 2) whether ERBB2 and PKM2 are key direct targets of miR-199/148 for regulating arsenic-induced transformation and tumor growth; and 3) whether PKM2/NF-:B interaction plays an important role. Aim 3 will investigate the mechanisms of arsenic-induced angiogenesis through miR-199/148/ERBB2/PKM2/NF-kB axis for inducing HIF-1 and IL- 8 via paracrine effect using animal models. We will also determine whether secretion of IL-8 will induce tumor angiogenesis through functional IL-8 receptors in endothelial cells (paracrine effect) using chimeric tumor model. This proposed study would provide an important paradigm shift in understanding how miRNAs regulate arsenic-induced tumor growth and angiogenesis through ERBB2 and PKM2/NF-kB axis. Given the important roles of ERBB2, PKM2, NF-kB, HIF-1, and IL-8 in different types of cancers; the proposed studies would be important for future studies on mechanism-based prevention and treatment for arsenic-induced cancer as well as other human cancers.
描述(由申请人提供):人体长期暴露于无机砷会诱发肺癌和其他癌症。砷致癌的分子机制仍有待阐明。我们的初步研究表明,砷增加活性氧(ROS)的产生,抑制miR-199和miR-148的表达,并增加ERBB 2,PKM 2,NF-kB,HIF-1和IL-8在肺上皮细胞中的表达。砷治疗还诱导细胞转化、肿瘤生长和血管生成。我们假设砷通过诱导NOX 2、p47 phox、ROS和DNMT 1表达抑制miR-199/148表达; miR-199/148下调通过ERBB 2和PKM 2/NF-:B靶点调节癌发生(细胞转化、肿瘤生长和血管生成)。为了验证这一假设,提出了三个目标。目的1探讨砷通过诱导NOX 2/p47 phox/DNMT 1、ROS生成抑制miR-199和miR-148表达,并通过下调miR-199/148进而调节ERBB 2表达和PKM 2/NF-kB相互作用的机制。我们将调查:1)砷是否通过诱导NOX 2、p47 Phox、ROS和DNMT 1抑制miR-199和miR-148表达; 2)砷是否通过下调miR-199/148诱导ERBB 2和PKM 2表达; 3)PKM 2的哪些区域与NF-κ B p65亚基结合以调节IL-8和HIF-1表达。目的2探讨miR-199/148下调在诱导ERBB 2和PKM 2/NF-kB表达中的作用,以调节细胞转化和肿瘤生长。我们将确定:1)砷是否通过ROS和DNMT 1诱导的miR-199/148下调来诱导细胞转化和肿瘤生长; 2)ERBB 2和PKM 2是否是miR-199/148调节砷诱导的转化和肿瘤生长的关键直接靶点; 3)PKM 2/NF-:B相互作用是否起重要作用。目的3通过miR-199/148/ERBB 2/PKM 2/NF-kB轴旁分泌诱导HIF-1和IL- 8表达,探讨砷诱导血管新生的机制。我们还将使用嵌合肿瘤模型确定IL-8的分泌是否会通过内皮细胞中的功能性IL-8受体(旁分泌效应)诱导肿瘤血管生成。这项研究将为理解miRNAs如何通过ERBB 2和PKM 2/NF-kB轴调节砷诱导的肿瘤生长和血管生成提供重要的范式转变。鉴于ERBB 2、PKM 2、NF-kB、HIF-1和IL-8在不同类型癌症中的重要作用,拟议的研究对于未来砷诱导的癌症以及其他人类癌症的基于机制的预防和治疗研究将是重要的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BingHua Jiang其他文献
BingHua Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BingHua Jiang', 18)}}的其他基金
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments
肺癌对酪氨酸激酶抑制剂和放射治疗的耐药机制
- 批准号:
10303868 - 财政年份:2018
- 资助金额:
$ 33.66万 - 项目类别:
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response
NOX4 介导卵巢肿瘤生长和治疗反应中的氧化应激
- 批准号:
9187916 - 财政年份:2015
- 资助金额:
$ 33.66万 - 项目类别:
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
活性氧诱导的 CXCL8 在卵巢癌中的作用
- 批准号:
8919299 - 财政年份:2014
- 资助金额:
$ 33.66万 - 项目类别:
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
活性氧诱导的 CXCL8 在卵巢癌中的作用
- 批准号:
8692266 - 财政年份:2014
- 资助金额:
$ 33.66万 - 项目类别:
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species
WC-Co纳米颗粒通过活性氧引发血管生成
- 批准号:
7851049 - 财政年份:2009
- 资助金额:
$ 33.66万 - 项目类别:
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species
WC-Co纳米颗粒通过活性氧引发血管生成
- 批准号:
7362918 - 财政年份:2009
- 资助金额:
$ 33.66万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 33.66万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 33.66万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 33.66万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 33.66万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 33.66万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 33.66万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 33.66万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 33.66万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 33.66万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 33.66万 - 项目类别:
Training Grant














{{item.name}}会员




